Delinia logo

Delinia

Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancing regulatory T cells to maintain immune system balance.

3 employees · est. 2015 · San Francisco, United States

VS
Q32 Bio Inc. logo

Q32 Bio Inc.

Revolutionizing the future of targeted immune therapeutics

28 employees · est. 2017 · Waltham, United States

Delinia is the older company (2015 vs 2017); Q32 Bio Inc. is the larger of the two.

Side-by-Side Comparison

Delinia Q32 Bio Inc.
Founded
2015 older 2017
Headquarters
San Francisco, United States Waltham, United States
Employees
3 28 larger
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Acquired Unknown
Total Funding
$335.00M $255.50M
Funding Rounds
2 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Autoimmune Disease Treatment, Inflammatory Disease Therapies, Regulatory T Cells, Tregs Expansion, Immune System Homeostasis, Novel Therapeutics, Self-tolerance Maintenance, Immune System Balance, Molecule Development, Autoimmune Pathophysiology, Therapeutic Innovation, Clinical Advancements, Immune Regulatory Cells, Scientific Discovery Immune Therapeutics, IL-7 Pathway, Complement System, Autoimmune Diseases, Inflammatory Diseases, Immunotherapy, Immune System Regulation, Treatment Options, Therapeutics Development, Dysregulation, Innovative Biotech, Immune Modulation, Precision Medicine, Startup Biotech
Website
deliniabio.com q32bio.com
Delinia logo

About Delinia

Delinia is a biotechnology company at the forefront of developing innovative treatments for autoimmune and inflammatory diseases. Founded in 2015 and headquartered in the United States, the company focuses on enhancing Regulatory T Cells (Tregs) to maintain immune system balance. These powerful immu...

Q32 Bio Inc. logo

About Q32 Bio Inc.

Q32 Bio Inc. is a leading biotechnology company with a mission to revolutionize the future of targeted immune therapeutics. Established in 2017, the company is headquartered in the United States. Q32 Bio is dedicated to developing innovative therapeutics that target powerful regulators of the innate...

We will tell you when either one moves

BounceWatch watches Delinia and Q32 Bio Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Delinia and Q32 Bio Inc. — by email.

Frequently Asked Questions

Delinia — Pioneering breakthrough treatments for autoimmune and inflammatory diseases with a focus on enhancing regulatory T cells to maintain immune system balance.. Q32 Bio Inc. — Revolutionizing the future of targeted immune therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Delinia has raised $335.00M while Q32 Bio Inc. has raised $255.50M.
Delinia and Q32 Bio Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Delinia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Delinia on 30 Mar 2026, and Q32 Bio Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy